BE446990A - - Google Patents

Info

Publication number

BE446990A

BE446990A BE446990DA BE446990A BE 446990 A BE446990 A BE 446990A BE 446990D A BE446990D A BE 446990DA BE 446990 A BE446990 A BE 446990A

Authority

BE

Belgium

Prior art keywords

selector

selectors

emergency

group

relay

Prior art date

Links

• Espacenet
• Global Dossier
• Discuss

• 210000000709 aorta Anatomy 0.000 claims 1
• 238000006073 displacement reaction Methods 0.000 claims 1
• 238000004804 winding Methods 0.000 description 27
• 239000004020 conductor Substances 0.000 description 18
• 239000003550 marker Substances 0.000 description 12
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
• 244000007853 Sarothamnus scoparius Species 0.000 description 8
• 238000012360 testing method Methods 0.000 description 8
• 230000005284 excitation Effects 0.000 description 5
• 229910052742 iron Inorganic materials 0.000 description 4
• 241000518994 Conta Species 0.000 description 3
• 230000000903 blocking effect Effects 0.000 description 3
• 230000000694 effects Effects 0.000 description 3
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
• 239000010931 gold Substances 0.000 description 3
• 229910052737 gold Inorganic materials 0.000 description 3
• 238000000034 method Methods 0.000 description 3
• 238000011160 research Methods 0.000 description 2
• WYFYSTBFFDOVJW-UHFFFAOYSA-L 2-[4-[4-(3,5-diphenyltetrazol-2-ium-2-yl)phenyl]phenyl]-3,5-diphenyltetrazol-2-ium;dichloride Chemical compound [Cl-].[Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC(=CC=2)C=2C=CC(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=NN1C1=CC=CC=C1 WYFYSTBFFDOVJW-UHFFFAOYSA-L 0.000 description 1
• BSFODEXXVBBYOC-UHFFFAOYSA-N 8-[4-(dimethylamino)butan-2-ylamino]quinolin-6-ol Chemical compound C1=CN=C2C(NC(CCN(C)C)C)=CC(O)=CC2=C1 BSFODEXXVBBYOC-UHFFFAOYSA-N 0.000 description 1
• 240000002234 Allium sativum Species 0.000 description 1
• 241000271560 Casuariidae Species 0.000 description 1
• 102100036044 Conserved oligomeric Golgi complex subunit 4 Human genes 0.000 description 1
• 206010011416 Croup infectious Diseases 0.000 description 1
• 102100035472 DNA polymerase iota Human genes 0.000 description 1
• 101000582396 Escherichia phage D108 Repressor c protein Proteins 0.000 description 1
• 101000582397 Escherichia phage Mu Repressor protein c Proteins 0.000 description 1
• 101000876012 Homo sapiens Conserved oligomeric Golgi complex subunit 4 Proteins 0.000 description 1
• 101001094672 Homo sapiens DNA polymerase iota Proteins 0.000 description 1
• 101001104102 Homo sapiens X-linked retinitis pigmentosa GTPase regulator Proteins 0.000 description 1
• 241000446313 Lamella Species 0.000 description 1
• 240000008154 Piper betle Species 0.000 description 1
• 235000008180 Piper betle Nutrition 0.000 description 1
• 208000036448 RPGR-related retinopathy Diseases 0.000 description 1
• 244000180577 Sambucus australis Species 0.000 description 1
• 235000018734 Sambucus australis Nutrition 0.000 description 1
• 201000000467 X-linked cone-rod dystrophy 1 Diseases 0.000 description 1
• 230000000712 assembly Effects 0.000 description 1
• 238000000429 assembly Methods 0.000 description 1
• 238000005282 brightening Methods 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 201000010549 croup Diseases 0.000 description 1
• 238000005034 decoration Methods 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• BCAARMUWIRURQS-UHFFFAOYSA-N dicalcium;oxocalcium;silicate Chemical compound [Ca+2].[Ca+2].[Ca]=O.[O-][Si]([O-])([O-])[O-] BCAARMUWIRURQS-UHFFFAOYSA-N 0.000 description 1
• 235000021183 entrée Nutrition 0.000 description 1
• 230000004438 eyesight Effects 0.000 description 1
• 235000004611 garlic Nutrition 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 1
• 230000002787 reinforcement Effects 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 230000002485 urinary effect Effects 0.000 description 1